Ovid Therapeutics Inc. (OVID) Total liabilities 2020–2025
Ovid Therapeutics Inc. (OVID) total liabilities at each fiscal year-end, per SEC filings.
$20.3MFY2025 · since FY2020: $32.3M → $20.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20.3M | -15.3% |
| FY2024 | $23.9M | -57.4% |
| FY2023 | $56.2M | +144.6% |
| FY2022 | $23.0M | +55.4% |
| FY2021 | $14.8M | -54.2% |
| FY2020 | $32.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More OVID financial trends
OVID RevenueOVID Net incomeOVID Net marginOVID Gross profitOVID Gross marginOVID Operating incomeOVID Operating marginOVID Operating cash flowOVID Free cash flowOVID Capital expendituresOVID Return on equityOVID Stock buybacksOVID Dividends paidOVID Total assetsOVID Shareholders’ equityOVID overview →